GLP-1 medications have dominated the weight-loss landscape this year — but some older Americans are reportedly kicking the trend to the curb. A study published in JAMA in January 2025 — which looked ...

With the U.S. Food and Drug Administration (FDA) approving pill versions of orforglipron (Foundayo) and semaglutide (Wegovy) for weight management, you might wonder how the side effects of ...

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in GLP-1 ...

According to the Longevity Biotechnology Association, a global nonprofit focused on preventing diseases associated with aging and extending people’s health spans, longevity drugs are medications that ...